理性指导指数:减少纳米医学创新冗余性的框架
1Department of Pharmaceutical Sciences, College of Pharmacy, Dubai Medical University, Dubai, UAE.
Nanomedicine (London, England)
|October 23, 2025
概括
纳米医学领域面临冗余,因为类似的药物输送平台. 一个新的框架和理性指导指数 (RGI) 工具旨在指导创新,优先考虑临床需求和可行性,以获得更好的患者结果.
科学领域:
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
- 生物技术是生物技术.
背景情况:
- 纳米载体已经推进了药物输送,提高了生物可用性并降低了毒性.
- 该领域充满了类似的纳米载体平台,导致冗余和停滞不前的转化进展.
研究的目的:
- 批判性地分析纳米载体开发中冗余性的驱动因素.
- 提出一个合理的创新框架和一个决策工具,以减轻冗余.
- 改善纳米医学进步的转化到临床实践中.
主要方法:
- 对促进纳米载体冗余性的科学和系统因素的分析.
- 制定一个合理的创新框架,强调基于需求的设计和比较基准测试.
- 引入理性指导指数 (RGI) 作为预启动分类工具.
主要成果:
- 确定了冗余的主要驱动因素:设计融合,专利战略,学术激励和缺乏比较标准.
- 提出了一个整合基于需求的设计,基准测试和预测建模的框架.
- 引入RGI以评估临床需求,创新价值和翻译可行性.
结论:
- 理性创新策略和结构化的决策工具,如RGI,对于推进纳米医学至关重要.
- 该RGI可以早期识别高风险项目,防止资源浪费.
- 采用这些策略将提高临床成功率和患者的治疗结果.
相关概念视频
Biopharmaceutical Factors Influencing Drug Product Design: Overview
232
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
232
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166
Therapeutic Index
6.6K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.6K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
404
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
404


